This article evaluates the evidence to support the use of biochemical measurement of significant reduction (SR) rates among pregnant smokers as a new behavioral indicator of « harm reduction » (HR).
The results of four studies-three randomized patient education clinical trials of pregnant smokers (Trials I, II, and In) and an epidemiological study (Study IV) - are presented.
Among Trial I, II, and III cohorts of pregnant smokers, control group SR rates of 7% (1), 9% (II), and 20% (III) were increased among experimental groups to 17% (I), 18% (II), and 32% (III) by the same patienteducation methods.
Analyses of infant birthweight data in Study IV found that a patient SR rate representing a 50% or more decrease between a baseline and follow-up test was associated with an increase in adjusted birthweight of 92 grams.
Mots-clés Pascal : Tabagisme, Toxicité, Homme, Femelle, Gestation, Prévention, Education santé, Alabama, Etats Unis, Amérique du Nord, Amérique, Epidémiologie, Méthodologie, Evaluation, Essai clinique
Mots-clés Pascal anglais : Tobacco smoking, Toxicity, Human, Female, Pregnancy, Prevention, Health education, Alabama, United States, North America, America, Epidemiology, Methodology, Evaluation, Clinical trial
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0483151
Code Inist : 002B03E. Création : 22/03/2000.